EdgarLookup
SC 13D/A

AMENDMENT NO. 2 TO SCHEDULE 13D

Company
Xenetic Biosciences, Inc.
Filed
March 18, 2024
Accession Number
0001213900-24-023384
View Document ↗ View on SEC.gov ↗